NNNils Netzer

Nils Netzer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nils Netzer has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    De-escalation of elective radiotherapy guided by FDG-PET lowers modeled late swallowing-related toxicity in head and neck cancer

    by Florian Stritzke, Katharina Dvornikovich, Hin Lau, Thomas Tessonnier, Philipp Schröter, David Neugebauer, Nils Netzer, Lukas Bauer, Rubens Thölken, Erik Winter, et al.

  • Open Access

    Abstract: Anatomy-informed Data Augmentation for Enhanced Prostate Cancer Detection

    by Balint Kovacs, Nils Netzer, Michael Baumgartner, Carolin Eith, Dimitrios Bounias, Clara Meinzer, Paul F. Jäger, Kevin S. Zhang, Ralf Floca, Adrian Schrader, et al.


  • Open Access

    Addressing image misalignments in multi-parametric prostate MRI for enhanced computer-aided diagnosis of prostate cancer

    by Balint Kovacs, Nils Netzer, Michael Baumgartner, Adrian Schrader, Fabian Isensee, Cedric Weißer, Ivo Wolf, Magdalena Görtz, Paul F. Jaeger, Victoria Schütz, et al.

    Prostate cancer (PCa) diagnosis on multi-parametric magnetic resonance images (MRI) requires radiologists with a high level of expertise. Misalignments between the MRI sequences can be caused by patient movement, elastic soft-tissue deformations, and imaging artifacts. They further increase the complexity of the task prompting radiologists to interpret the images. Recently, computer-aided diagnosis (CAD) tools have demonstrated potential for PCa diagnosis typically relying on complex co-registration of the input modalities. However, there is no consensus among research groups on whether CAD systems profit from using registration. Furthermore, alternative strategies to handle multi-modal misalignments have not been explored so far. Our study introduces and compares different strategies to cope with image misalignments and evaluates them regarding to their direct effect on diagnostic accuracy of PCa. In addition to established registration algorithms, we propose ‘misalignment augmentation’ as a concept to increase CAD robustness. As the results demonstrate, misalignment augmentations can not only compensate for a complete lack of registration, but if used in conjunction with registration, also improve the overall performance on an independent test set.


  • Anatomy-Informed Data Augmentation for Enhanced Prostate Cancer Detection

    by Balint Kovacs, Nils Netzer, Michael Baumgartner, Carolin Eith, Dimitrios Bounias, Clara Meinzer, Paul F. Jäger, Kevin S. Zhang, Ralf Floca, Adrian Schrader, et al.


  • Open Access

    Anatomy-informed Data Augmentation for Enhanced Prostate Cancer Detection

    by Balint Kovacs, Nils Netzer, Michael Baumgartner, Carolin Eith, Dimitrios Bounias, Clara Meinzer, Paul F. Jaeger, Kevin S. Zhang, Ralf Floca, Adrian Schrader, et al.

    Data augmentation (DA) is a key factor in medical image analysis, such as in prostate cancer (PCa) detection on magnetic resonance images. State-of-the-art computer-aided diagnosis systems still rely on simplistic spatial transformations to preserve the pathological label post transformation. However, such augmentations do not substantially increase the organ as well as tumor shape variability in the training set, limiting the model's ability to generalize to unseen cases with more diverse localized soft-tissue deformations. We propose a new anatomy-informed transformation that leverages information from adjacent organs to simulate typical physiological deformations of the prostate and generates unique lesion shapes without altering their label. Due to its lightweight computational requirements, it can be easily integrated into common DA frameworks. We demonstrate the effectiveness of our augmentation on a dataset of 774 biopsy-confirmed examinations, by evaluating a state-of-the-art method for PCa detection with different augmentation settings.

  • Open Access

    Application of a validated prostate MRI deep learning system to independent same-vendor multi-institutional data: demonstration of transferability

    by Nils Netzer, Carolin Eith, Oliver Bethge, Thomas Hielscher, Constantin Schwab, Albrecht Stenzinger, Regula Gnirs, Heinz-Peter Schlemmer, Klaus H. Maier-Hein, Lars Schimmöller, et al.

    Objectives: To evaluate a fully automatic deep learning system to detect and segment clinically significant prostate cancer (csPCa) on same-vendor prostate MRI from two different institutions not contributing to training of the system. Materials and methods: In this retrospective study, a previously bi-institutionally validated deep learning system (UNETM) was applied to bi-parametric prostate MRI data from one external institution (A), a PI-RADS distribution-matched internal cohort (B), and a csPCa stratified subset of single-institution external public challenge data (C). csPCa was defined as ISUP Grade Group ≥ 2 determined from combined targeted and extended systematic MRI/transrectal US-fusion biopsy. Performance of UNETM was evaluated by comparing ROC AUC and specificity at typical PI-RADS sensitivity levels. Lesion-level analysis between UNETM segmentations and radiologist-delineated segmentations was performed using Dice coefficient, free-response operating characteristic (FROC), and weighted alternative (waFROC). The influence of using different diffusion sequences was analyzed in cohort A. Results: In 250/250/140 exams in cohorts A/B/C, differences in ROC AUC were insignificant with 0.80 (95% CI: 0.74–0.85)/0.87 (95% CI: 0.83–0.92)/0.82 (95% CI: 0.75–0.89). At sensitivities of 95% and 90%, UNETM achieved specificity of 30%/50% in A, 44%/71% in B, and 43%/49% in C, respectively. Dice coefficient of UNETM and radiologist-delineated lesions was 0.36 in A and 0.49 in B. The waFROC AUC was 0.67 (95% CI: 0.60–0.83) in A and 0.7 (95% CI: 0.64–0.78) in B. UNETM performed marginally better on readout-segmented than on single-shot echo-planar-imaging. Conclusion: For same-vendor examinations, deep learning provided comparable discrimination of csPCa and non-csPCa lesions and examinations between local and two independent external data sets, demonstrating the applicability of the system to institutions not participating in model training. Clinical relevance statement: A previously bi-institutionally validated fully automatic deep learning system maintained acceptable exam-level diagnostic performance in two independent external data sets, indicating the potential of deploying AI models without retraining or fine-tuning, and corroborating evidence that AI models extract a substantial amount of transferable domain knowledge about MRI-based prostate cancer assessment. Key Points: • A previously bi-institutionally validated fully automatic deep learning system maintained acceptable exam-level diagnostic performance in two independent external data sets. • Lesion detection performance and segmentation congruence was similar on the institutional and an external data set, as measured by the weighted alternative FROC AUC and Dice coefficient. • Although the system generalized to two external institutions without re-training, achieving expected sensitivity and specificity levels using the deep learning system requires probability thresholds to be adjusted, underlining the importance of institution-specific calibration and quality control.